Filing Details
- Accession Number:
- 0001127602-17-000742
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-04 17:32:14
- Reporting Period:
- 2017-01-03
- Filing Date:
- 2017-01-04
- Accepted Time:
- 2017-01-04 17:32:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711404 | Cooper Companies Inc | COO | Ophthalmic Goods (3851) | 942657368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1183216 | Michael Kalkstein | 6140 Stoneridge Mall Drive Suite 590 Pleasanton CA 94588 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-01-03 | 9,000 | $42.49 | 9,899 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-01-03 | 2,607 | $174.82 | 7,292 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-01-03 | 6,393 | $175.40 | 899 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2017-01-03 | 9,000 | $0.00 | 9,000 | $42.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-10-31 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 7,816 | Indirect | The Kalkstein and English Family Trust u/a/d May 18, 2005 |
Footnotes
- Sale price represents an average of sale prices ranging from $174.625 to $174.940.
- Sale price represents an average of sale prices ranging from $175.000 to $175.960.
- All shares granted under this option are currently exercisable.